Missing/wrong data?
Log in to edit
Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma
scientific article
Author/s
author: Henry Seth Friedman, Sridharan Gururangan, Annick Desjardins, Allan Friedman, David A Reardon, Roger E McLendon, James J Vredenburgh, Katherine B Peters, James H. Herndon, Stevie Threatt
Work details
Publication date
October 11, 2011
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.